Olatorepatide Obesity Treatment Licensed by Regeneron Demonstrates Positive Phase 3 Results in Chinese Patients 09 March
Dupixent® Recommended for EU Approval to Treat Chronic Spontaneous Urticaria in Young Children with Ongoing Symptoms Despite Treatment 27 February
